Publications

06 Sep 2019
Blog Post

The Business of Medicine: MD/MBA Students Having an Impact

change both small and large: improving how operating rooms function, and “instituting changes from an administrative perspective” that would address socioeconomic inequalities. All with the goal of changing how health care is delivered. A... View Details

15 Aug 2011
Research & Ideas

A New Model for Business: The Museum

Groupon's success is borne of the careful way the company presents wares to its customers: providing a very limited amount of choices at a time, along with a brief, engaging description of each offering. To that end, Weaver is exploring... View Details

Keywords: by Carmen Nobel

31 Mar 2023
Research & Ideas

Can a ‘Basic Bundle’ of Health Insurance Cure Coverage Gaps and Spur Innovation?

policies that amount to a “fragmented insurance system” that leaves 10 percent of the population uninsured, according to research by Harvard Business School Professor Amitabh Chandra. “The United States spends substantially more on health View Details

Keywords: by Kasandra Brabaw; Insurance; Health

August 2008 (Revised May 2009)
Background Note

Note on Generic Drugs in the European Union

By: Robert C. Pozen and Elizabeth M. Leonard

Rules governing the introduction of generic drugs in U.S. and EU have some similarities but significant differences because of the Hatch-Waxman Act in the U.S. View Details

Keywords: Governing Rules, Regulations, and Reforms; Government Legislation; Health Care and Treatment; Trademarks; Brands and Branding; Pharmaceutical Industry; European Union; United States

Find at Harvard

16 Jul 2008
Op-Ed

What Should Employers Do about Health Care?

have a strategic role to play in improving value in the health care system. Rather than disenfranchising employers, policymakers would be well advised to harness this role. Employers, for their part, need to recognize their fundamental... View Details

Keywords: by Michael E. Porter, Elizabeth O. Teisberg & Scott Wallace; Health

May 4, 2023
Article

Falling Insulin Prices—What Just Happened?

By: Leemore S. Dafny

Recently, more than 100 years after insulin was developed, manufacturers announced price reductions for insulin products. Pressure to reduce prices had long been building, so why would they act now? View Details

Keywords: Price; Health Care and Treatment; Public Opinion; Demand and Consumers; Pharmaceutical Industry

Find at Harvard

Register to Read

2020
Working Paper

Spreading the Health: Americans' Estimated and Ideal Distributions of Death and Health(care)

By: Sorapop Kiatpongsan and Michael I. Norton

The 2010 Patient Protection and Affordable Care Act intensified debates over the role of government in the distribution of healthcare. A nationally-representative sample of Americans reported their estimated and ideal distributions of healthcare (unmet need for... View Details

Keywords: Healthcare; Mortality; Inequality; Justice; Equity; Health; Health Care and Treatment; Equality and Inequality; Fairness; Public Opinion; United States

SSRN

Read Now

January 2019 (Revised June 2019)
Technical Note

U.S. Commercial Health Insurance Industry

By: Susanna Gallani, Mary Witkowski and Harry B. Wolberg

This note describes the role of commercial payers in the U.S. healthcare industry. We begin with a review of the historical evolution of commercial payers and their role in the market, from the beginning to the Affordable Care Act and beyond. Every wave of reforms in... View Details

Keywords: Health Care and Treatment; Insurance; Governing Rules, Regulations, and Reforms; Organizational Change and Adaptation; Health Industry; Insurance Industry; United States

18 Dec 2018
First Look

New Research and Ideas, December 18, 2018

2018 Innovation Policy and the Economy The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century By: Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern Abstract—On the 35th... View Details

Keywords: Dina Gerdeman

03 Nov 2003
What Do You Think?

Can Investors Have Too Much Accounting Transparency?

insiders of the insider's equity..." Several respondents suggested the need for a careful approach to the issue of greater transparency. E. Smith asked, "Do investors care about immaterial... View Details

Keywords: by James Heskett

13 Nov 2000
Research & Ideas

Managing to Learn: How Companies Can Turn Knowledge into Action

alone do not a learning organization make. The necessary complement is a mind-set of inquiry and experimentation, plus a knowledge-sharing process that enables everyone in a company to act in an informed way upon what's been learned... View Details

Keywords: by Laurie Joan Aron

2010
Working Paper

Quality Provision, Expected Firm Altruism and Brand Extensions

By: Julio J. Rotemberg

This paper studies quality choice in a model where consumers expect firms to act altruistically. It is shown that, under plausible assumptions regarding this altruism and the reaction of consumers to firms that demonstrate insufficient altruism, existing firms (or... View Details

Keywords: Brands and Branding; Consumer Behavior; Product Development; Corporate Social Responsibility and Impact; Quality; Mathematical Methods

Read Now

June 2010 (Revised September 2010)
Case

athenahealth: Innovating in Response to a Crisis in Healthcare

When Jonathan Bush and his partner, Todd Park, realized that their revolutionary approach to delivering clinical care was being stymied by the inefficiencies in the healthcare system and insurance red tape, they turned their proprietary technology, athenaNet, to a new... View Details

Keywords: Entrepreneurship; Health Care and Treatment; Information Management; Innovation and Invention; Brands and Branding; Product Development; Health Industry; United States

20 Jul 2020
Op-Ed

It's Time for a Bipartisan Health Plan for Employers and Employees

under the Affordable Care Act (ACA) or Medicaid.) Some contend that the Public Option’s low-cost premiums are falsely achieved by shifting Medicare’s costs to private insurers, but Medicare’s massive... View Details

Keywords: by Regina E. Herzlinger and Richard J. Boxer; Health; Insurance

January 2005 (Revised March 2006)
Case

Molecular Insight Pharmaceuticals, Inc.

By: Richard G. Hamermesh and Edwin W. Parkinson III

Molecular Insight has developed a novel biopharmaceutical to detect heart attacks. The company's unique approach to intellectual property protection uses the Hatch Waxman Act and the Orphan Drug Act. The company is struggling to raise $7 million in Series B financing.... View Details

Keywords: Intellectual Property; Health Care and Treatment; Pharmaceutical Industry; Health Industry

2014
Working Paper

The Triumph of the Humble Chief Risk Officer

By: Anette Mikes

This paper tracks the evolution of the role of two chief risk officers (CROs), and the tools and processes they have implemented in their respective organizations. While the companies are from very different industries (one is a power company, the other is a toy... View Details

Keywords: Risk Management; Managerial Roles

Read Now

14 Mar 2017
First Look

First Look at New Research, March 14

of a Leadership Team BrightStar Care was a rapidly growing franchise of home health care agencies. Founded by husband and wife team JD and Shelly Sun as a single agency near Chicago in 2002, BrightStar had... View Details

Keywords: Sean Silverthorne

2023
Working Paper

Saving and Consumption Responses to Student Loan Forbearance

By: Justin Katz

How do households adjust savings and consumption in response to liquidity from debt relief? I study this question using policy variation induced by federal student loan forbearance in the 2020 CARES Act and an individual-level panel of daily financial transactions for... View Details

Keywords: Saving; Consumer Behavior; Borrowing and Debt; Interest Rates; Financial Liquidity; Personal Finance; Government Legislation